De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients (clinicaltrials.gov) - May 15, 2025 - P3 | N=60 | Recruiting | Sponsor: Virginia Commonwealth University | Phase classification: P4 ➔ P3
Phase classification • Cytomegalovirus Infection • Transplantation • CYP3A5
|